MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Recruiting · NCT07391839 · Registry updated 2026-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma. | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 1 | 2026-02-06 | NCT07391839 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou Mednovo Yi Medical Technology Co., Ltd. | 1 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Provincial Hospital | Hefei | China | 32 |
| Henan Cancer Hospital | Henan | China | 1 |
| Shandong Cancer Hospital | Jinan | China | 86 |
| The First Affiliated Hospital of Fujian Medical University | Fuzhou | China | 53 |
| The First Affiliated Hospital of Jinan University | Guangzhou | China | 9 |
| Zhejiang Cancer Hospital | Hangzhou | China | 164 |
| Zhongda Hospital | Nanjing | China | 7 |
| Zhongshan Hospital | Shanghai | China | 7 |